Benjamin Hickey - Net Worth and Insider Trading
Benjamin Hickey Net Worth
The estimated net worth of Benjamin Hickey is at least $7 Million dollars as of 2024-11-05. Benjamin Hickey is the EVP, Chief Commercial Officer of Mirati Therapeutics Inc and owns about 117,028 shares of Mirati Therapeutics Inc (MRTX) stock worth over $7 Million. Details can be seen in Benjamin Hickey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Benjamin Hickey has not made any transactions after 2024-01-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Benjamin Hickey
Benjamin Hickey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Benjamin Hickey owns 3 companies in total, including Mirati Therapeutics Inc (MRTX) , Halozyme Therapeutics Inc (HALO) , and Surface Oncology Inc (SURF) .
Click here to see the complete history of Benjamin Hickey’s form 4 insider trades.
Insider Ownership Summary of Benjamin Hickey
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MRTX | Mirati Therapeutics Inc | 2024-01-16 | EVP & Chief Commercial Officer |
HALO | Halozyme Therapeutics Inc | 2019-10-01 | SVP & Chief Commerical Officer |
SURF | Surface Oncology Inc | 2021-12-09 | director |
Benjamin Hickey Latest Holdings Summary
Benjamin Hickey currently owns a total of 1 stock. Benjamin Hickey owns 117,028 shares of Mirati Therapeutics Inc (MRTX) as of January 16, 2024, with a value of $7 Million.
Latest Holdings of Benjamin Hickey
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MRTX | Mirati Therapeutics Inc | 2024-01-16 | 117,028 | 58.70 | 6,869,544 |
Holding Weightings of Benjamin Hickey
Benjamin Hickey Form 4 Trading Tracker
According to the SEC Form 4 filings, Benjamin Hickey has made a total of 10 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 1,597 shares on January 16, 2024, which brought Benjamin Hickey around $94,255.
Insider Trading History of Benjamin Hickey
- 1
Benjamin Hickey Trading Performance
Benjamin Hickey Ownership Network
Ownership Network List of Benjamin Hickey
Ownership Network Relation of Benjamin Hickey
Benjamin Hickey Owned Company Details
What does Mirati Therapeutics Inc do?
Who are the key executives at Mirati Therapeutics Inc?
Benjamin Hickey is the EVP & Chief Commercial Officer of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include Sr. Vice President & Chief Scie Jamie Christensen , Interim CFO Aaron Ondrey , and other: See remarks Mva Investors, Llc .
Mirati Therapeutics Inc (MRTX) Insider Trades Summary
Over the past 18 months, Benjamin Hickey made 3 insider transaction in Mirati Therapeutics Inc (MRTX) with a net sale of 5,907. Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 8,522 shares made by Jamie Christensen , a net purchase of 2,517,946 shares made by Boxer Capital, Llc , and a net purchase of 10,791 shares made by Faheem Hasnain .
In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,076 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,509,661 shares.
Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirati Therapeutics Inc Insider Transactions
Benjamin Hickey Mailing Address
Above is the net worth, insider trading, and ownership report for Benjamin Hickey. You might contact Benjamin Hickey via mailing address: C/o Mirati Therapeutics, 9393 Towne Centre Drive Suite 200, San Diego Ca 92121.